Phase III Clinical Study Evaluating the Safety, Pharmacokinetics, and Efficacy of JKN2301 Dry Suspension in Pediatric Patients Aged 2 to Under 12 Years With Influenza
Clinical trial NCT07357051 · RECRUITING
Trial details
- NCT number
- NCT07357051
- Sponsor
- Joincare Pharmaceutical Group Industry Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-07
- Primary completion
- 2026-01-31
- Enrollment
- 177
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.